Chemed Corp (NYSE:CHE)
$ 570.79 -4.45 (-0.77%) Market Cap: 8.61 Bil Enterprise Value: 8.51 Bil PE Ratio: 30.72 PB Ratio: 7.27 GF Score: 96/100

Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 14, 2023 / 05:20PM GMT
Release Date Price: $516 (+2.07%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good afternoon. Welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Mike Wiederhorn, the healthcare services analyst. It's my pleasure to have Chemed Corporation today. We have President and CEO, Kevin McNamara; and Chief Financial Officer, David Williams. This is going to be fireside. Welcome, guys. Thanks for joining us today.

David P. Williams
Chemed Corporation - Executive VP & CFO

Thanks, Mike.

Questions & Answers

Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Thank you. I'll start off with a general question. Can you just kind of give us your thoughts around now that you're a few months into 2023 under your belt, how should we view trends in the business? And do you think we can use this year as a normalized base to grow off of?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot